Gertraud Maskarinec to Isoflavones
This is a "connection" page, showing publications Gertraud Maskarinec has written about Isoflavones.
Connection Strength
5.210
-
Morimoto Y, Beckford F, Franke AA, Maskarinec G. Urinary isoflavonoid excretion as a biomarker of dietary soy intake during two randomized soy trials. Asia Pac J Clin Nutr. 2014; 23(2):205-9.
Score: 0.449
-
Messina M, Caan BJ, Abrams DI, Hardy M, Maskarinec G. It's time for clinicians to reconsider their proscription against the use of soyfoods by breast cancer patients. Oncology (Williston Park). 2013 May; 27(5):430-7.
Score: 0.428
-
Maskarinec G. The human mammary gland as a target for isoflavones: how does the relation vary in individuals with different ethnicity? Planta Med. 2013 May; 79(7):554-61.
Score: 0.415
-
Sen C, Morimoto Y, Heak S, Cooney RV, Franke AA, Maskarinec G. Soy foods and urinary isoprostanes: results from a randomized study in premenopausal women. Food Funct. 2012 May; 3(5):517-21.
Score: 0.394
-
Maskarinec G, Verheus M, Steinberg FM, Amato P, Cramer MK, Lewis RD, Murray MJ, Young RL, Wong WW. Various doses of soy isoflavones do not modify mammographic density in postmenopausal women. J Nutr. 2009 May; 139(5):981-6.
Score: 0.322
-
Maskarinec G, Oum R, Chaptman AK, Ognjanovic S. Inflammatory markers in a randomised soya intervention among men. Br J Nutr. 2009 Jun; 101(12):1740-4.
Score: 0.316
-
Maskarinec G, Watts K, Kagihara J, Hebshi SM, Franke AA. Urinary isoflavonoid excretion is similar after consuming soya milk and miso soup in Japanese-American women. Br J Nutr. 2008 Aug; 100(2):424-9.
Score: 0.298
-
Maskarinec G, Hebshi S, Custer L, Franke AA. The relation of soy intake and isoflavone levels in nipple aspirate fluid. Eur J Cancer Prev. 2008 Feb; 17(1):67-70.
Score: 0.298
-
Franke AA, Morimoto Y, Yeh LM, Maskarinec G. Urinary isoflavonoids as a dietary compliance measure among premenopausal women. Asia Pac J Clin Nutr. 2006; 15(1):88-94.
Score: 0.258
-
Maskarinec G, Morimoto Y, Novotny R, Nordt FJ, Stanczyk FZ, Franke AA. Urinary sex steroid excretion levels during a soy intervention among young girls: a pilot study. Nutr Cancer. 2005; 52(1):22-8.
Score: 0.240
-
Maskarinec G, Robbins C, Riola B, Kane-Sample L, Franke AA, Murphy S. Three measures show high compliance in a soy intervention among premenopausal women. J Am Diet Assoc. 2003 Jul; 103(7):861-6.
Score: 0.217
-
Maskarinec G, Williams AE, Inouye JS, Stanczyk FZ, Franke AA. A randomized isoflavone intervention among premenopausal women. Cancer Epidemiol Biomarkers Prev. 2002 Feb; 11(2):195-201.
Score: 0.196
-
Frankenfeld CL, Maskarinec G, Franke AA. Metabolomics profiles of premenopausal women are different based on O-desmethylangolensin metabotype. Br J Nutr. 2022 10 28; 128(8):1490-1498.
Score: 0.193
-
Rohrmann S, Shvetsov YB, Morimoto Y, Wilkens LR, Monroe KR, Le Marchand L, Franke AA, Kolonel LN, Maskarinec G. Self-reported dietary flavonoid intake and serum markers of inflammation: the multiethnic cohort. Cancer Causes Control. 2018 06; 29(6):601-607.
Score: 0.151
-
Maskarinec G, Ju D, Morimoto Y, Franke AA, Stanczyk FZ. Soy Food Intake and Biomarkers of Breast Cancer Risk: Possible Difference in Asian Women? Nutr Cancer. 2017 01; 69(1):146-153.
Score: 0.137
-
Morimoto Y, Maskarinec G, Park SY, Ettienne R, Matsuno RK, Long C, Steffen AD, Henderson BE, Kolonel LN, Le Marchand L, Wilkens LR. Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort. Br J Nutr. 2014 Sep 28; 112(6):976-83.
Score: 0.118
-
Maskarinec G, Morimoto Y, Heak S, Isaki M, Steinbrecher A, Custer L, Franke AA. Urinary estrogen metabolites in two soy trials with premenopausal women. Eur J Clin Nutr. 2012 Sep; 66(9):1044-9.
Score: 0.101
-
Morimoto Y, Conroy SM, Pagano IS, Isaki M, Franke AA, Nordt FJ, Maskarinec G. Urinary estrogen metabolites during a randomized soy trial. Nutr Cancer. 2012; 64(2):307-14.
Score: 0.098
-
Franke AA, Lai JF, Pagano I, Morimoto Y, Maskarinec G. Equol production changes over time in pre-menopausal women. Br J Nutr. 2012 Apr; 107(8):1201-6.
Score: 0.096
-
Maskarinec G, Morimoto Y, Conroy SM, Pagano IS, Franke AA. The volume of nipple aspirate fluid is not affected by 6 months of treatment with soy foods in premenopausal women. J Nutr. 2011 Apr 01; 141(4):626-30.
Score: 0.092
-
Maskarinec G, Verheus M, Tice JA. Epidemiologic studies of isoflavones & mammographic density. Nutrients. 2010 01; 2(1):35-48.
Score: 0.085
-
Maskarinec G, Takata Y, Murphy SP, Franke AA, Kaaks R. Insulin-like growth factor-1 and binding protein-3 in a 2-year soya intervention among premenopausal women. Br J Nutr. 2005 Sep; 94(3):362-7.
Score: 0.063
-
Maskarinec G, Takata Y, Franke AA, Williams AE, Murphy SP. A 2-year soy intervention in premenopausal women does not change mammographic densities. J Nutr. 2004 Nov; 134(11):3089-94.
Score: 0.059
-
Maskarinec G, Franke AA, Williams AE, Hebshi S, Oshiro C, Murphy S, Stanczyk FZ. Effects of a 2-year randomized soy intervention on sex hormone levels in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2004 Nov; 13(11 Pt 1):1736-44.
Score: 0.059
-
Takata Y, Maskarinec G, Franke A, Nagata C, Shimizu H. A comparison of dietary habits among women in Japan and Hawaii. Public Health Nutr. 2004 Apr; 7(2):319-26.
Score: 0.057
-
Williams AE, Maskarinec G, Hebshi S, Oshiro C, Murphy S, Franke AA. Validation of a soy questionnaire with repeated dietary recalls and urinary isoflavone assessments over one year. Nutr Cancer. 2003; 47(2):118-25.
Score: 0.052
-
Takata Y, Maskarinec G, Rinaldi S, Kaaks R, Nagata C. Serum insulin-like growth factor-I levels among women in Hawaii and Japan with different levels of tofu intake. Nutr Cancer. 2006; 56(2):136-42.
Score: 0.016